|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.05 HKD | -0.06% |
|
+10.55% | +143.31% |
| Capitalization | 139B 152B 19.4B 16.64B 15.51B 14.43B 26.62B 1,671B 29.72B 187B 70.72B 783B 72.76B 71.25B 2,879B | P/E ratio 2025 * |
339x | P/E ratio 2026 * | 97.9x |
|---|---|---|---|---|---|
| Enterprise value | 133B 145B 18.47B 15.84B 14.76B 13.74B 25.34B 1,590B 28.3B 178B 67.32B 746B 69.27B 67.83B 2,741B | EV / Sales 2025 * |
11.2x | EV / Sales 2026 * | 9.07x |
| Free-Float |
93.21% | Yield 2025 * |
-
| Yield 2026 * | 0.01% |
More valuation ratios
* Estimated data
More news
Last Transcript: Innovent Biologics, Inc.
More recommendations
More press releases
More news
| 1 day | -0.06% | ||
| 1 week | +10.55% | ||
| Current month | +13.58% | ||
| 1 month | +13.30% | ||
| 3 months | +88.47% | ||
| 6 months | +183.15% | ||
| Current year | +143.31% |
| 1 week | 79.5 |  | 91.7 |
| 1 month | 75.15 | | 91.7 |
| Current year | 28.65 | | 91.7 |
| 1 year | 28.65 | | 91.7 |
| 3 years | 21.2 | | 91.7 |
| 5 years | 18.06 | | 107.1 |
| 10 years | 14 | | 107.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 61 | 27/04/2011 |
Fei You
DFI | Director of Finance/CFO | 46 | 04/02/2024 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
De Chao Yu
CHM | Chairman | 61 | 27/04/2011 |
Charles Cooney
BRD | Director/Board Member | 80 | 17/10/2015 |
Hao Xi Ede
BRD | Director/Board Member | 66 | 03/06/2018 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 1.78% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.06% | +10.55% | +118.53% | +146.33% | 19.4B | ||
| +3.62% | +6.83% | -17.43% | -11.45% | 81.33B | ||
| -1.36% | -4.44% | -48.99% | -8.93% | 57.33B | ||
| -1.78% | +5.10% | +23.65% | +29.75% | 53.86B | ||
| +0.49% | +2.28% | +27.49% | +106.34% | 38.73B | ||
| +0.31% | +11.62% | +86.31% | +820.19% | 18.86B | ||
| -2.88% | -6.87% | -44.79% | -43.25% | 18.31B | ||
| -0.04% | -.--% | +76.16% | +135.78% | 14.02B | ||
| -1.57% | -1.06% | +3.02% | -16.59% | 13.14B | ||
| -2.92% | -7.07% | -74.20% | -81.30% | 12.09B | ||
| Average | -0.62% | +1.32% | +14.97% | +107.69% | 32.71B | |
| Weighted average by Cap. | +0.11% | +1.96% | +4.37% | +68.77% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 11.82B 12.92B 1.65B 1.41B 1.32B 1.22B 2.26B 142B 2.52B 15.9B 6B 66.49B 6.18B 6.05B 244B | 14.53B 15.88B 2.02B 1.74B 1.62B 1.51B 2.78B 174B 3.1B 19.54B 7.38B 81.7B 7.59B 7.43B 300B |
| Net income | 369M 404M 51.46M 44.16M 41.14M 38.28M 70.62M 4.43B 78.86M 497M 188M 2.08B 193M 189M 7.64B | 1.31B 1.43B 183M 157M 146M 136M 251M 15.73B 280M 1.76B 666M 7.37B 685M 671M 27.11B |
| Net Debt | -6.69B -7.31B -931M -799M -745M -693M -1.28B -80.22B -1.43B -9B -3.4B -37.61B -3.49B -3.42B -138B | -7.48B -8.18B -1.04B -894M -833M -775M -1.43B -89.76B -1.6B -10.07B -3.8B -42.08B -3.91B -3.83B -155B |
More financial data
* Estimated data
Employees
5,659
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/07/25 | 89.05 $ | -0.06% | 15,552,330 |
| 17/07/25 | 89.10 $ | +3.36% | 25,428,840 |
| 16/07/25 | 86.20 $ | +0.35% | 13,874,370 |
| 15/07/25 | 85.90 $ | +4.76% | 20,341,030 |
| 14/07/25 | 82.00 $ | +1.80% | 17,319,030 |
Delayed Quote Hong Kong S.E., July 18, 2025 at 09:08 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
81.47CNY
Average target price
77.23CNY
Spread / Average Target
-5.21%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1801 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition